Unity Biotechnology, Inc.UBXNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank0
3Y CAGR-30.3%
5Y CAGR-28.8%
Year-over-Year Change
Research and development spending
3Y CAGR
-30.3%/yr
vs +0.7%/yr prior
5Y CAGR
-28.8%/yr
Consistent
Acceleration
-31.0pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
5 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $13.01M | -37.5% |
| 2023 | $20.80M | -43.6% |
| 2022 | $36.86M | -4.0% |
| 2021 | $38.39M | -43.0% |
| 2020 | $67.31M | -5.1% |
| 2019 | $70.96M | +20.5% |
| 2018 | $58.91M | +57.6% |
| 2017 | $37.37M | +172.7% |
| 2016 | $13.71M | - |